| YML090W |
Saccharomyces cerevisiae |
|
YML090W is differentially expressed in 9 experiments [16 up/12 dn]: 2 compound treatments: doxycycline [1 up/0 dn], none [0 up/1 dn], 2 developmental stages: mitotic growth [0 up/1 dn], meiotic development [1 up/0 dn], 6 genotypes, 8 growth conditions, 2 temperatures |
| YML090W |
|
|
| integral to membrane |
|
|
|
Q04501
|
|
|
|
YML090W
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Control
|
Growth condition |
|
|
Rehydration
|
Growth condition |
|
|
50% dessication
|
Growth condition |
|
|
Dessication
|
Growth condition |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
SPII media
|
Growth condition |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
Doxycycline
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
Nitrogen limited
|
Growth condition |
|
|
Carbon limited
|
Growth condition |
|
|
Alpha ade2-1 his3- leu2-3,112 ...
|
Genotype |
|
|
28 degree_C
|
Temperature |
|
|
Alpha ade2-1 his3- leu2-3,112 ...
|
Genotype |
|
|
25 degree_C
|
Temperature |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Wild_type
|
Genotype |
|
|
YPD media
|
Growth condition |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
|
|
|
Processing time: 0.025 secs.